Literature DB >> 19159391

Noncoding RNAs in mental retardation.

K E Szulwach1, P Jin, R S Alisch.   

Abstract

Recent genome-wide interrogations of transcribed RNA have yielded compelling evidence for pervasive and complex transcription throughout a large majority of the human genome. Tens of thousands of noncoding RNA transcripts have been identified, most of which have yet to be functionally characterized. Along with the revelation that noncoding RNAs in the human genome are surprisingly abundant, there has been a surge in molecular and genetic data showing important and diverse regulatory roles for noncoding RNA. In this report, we summarize the potential roles that noncoding RNAs may play in the molecular pathogenesis of different mental retardation disorders. We suspect that these findings are just the tip of the iceberg, with noncoding RNAs possibly being involved in disease pathogenesis at different levels and through multiple distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159391      PMCID: PMC3270373          DOI: 10.1111/j.1399-0004.2008.01134.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  90 in total

1.  Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain.

Authors:  Rong Mao; Carol L Zielke; H Ronald Zielke; Jonathan Pevsner
Journal:  Genomics       Date:  2003-05       Impact factor: 5.736

2.  The proteins of human chromosome 21.

Authors:  Katheleen Gardiner; Alberto C S Costa
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

3.  An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals.

Authors:  Paula D Ladd; Leslie E Smith; Natalia A Rabaia; James M Moore; Sara A Georges; R Scott Hansen; Randi J Hagerman; Flora Tassone; Stephen J Tapscott; Galina N Filippova
Journal:  Hum Mol Genet       Date:  2007-10-06       Impact factor: 6.150

4.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

5.  The fragile X mental retardation protein inhibits translation via interacting with mRNA.

Authors:  Z Li; Y Zhang; L Ku; K D Wilkinson; S T Warren; Y Feng
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

6.  The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain.

Authors:  C Rougeulle; H Glatt; M Lalande
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA.

Authors:  Matthew E Klein; Daniel T Lioy; Lin Ma; Soren Impey; Gail Mandel; Richard H Goodman
Journal:  Nat Neurosci       Date:  2007-11-11       Impact factor: 24.884

8.  Fragile X-related protein and VIG associate with the RNA interference machinery.

Authors:  Amy A Caudy; Mike Myers; Gregory J Hannon; Scott M Hammond
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

Review 9.  The Odyssey of MeCP2 and parental imprinting.

Authors:  Janine M LaSalle
Journal:  Epigenetics       Date:  2006-12-12       Impact factor: 4.528

10.  G-quartet-dependent recognition between the FMRP RGG box and RNA.

Authors:  Andres Ramos; David Hollingworth; Annalisa Pastore
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

View more
  8 in total

1.  MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.

Authors:  Ji Hyae Lim; Da Eun Lee; Shin Young Kim; Hyun Jin Kim; Kyeong Sun Kim; You Jung Han; Min Hyoung Kim; Jun Seek Choi; Moon Young Kim; Hyun Mee Ryu; So Yeon Park
Journal:  J Assist Reprod Genet       Date:  2015-03-08       Impact factor: 3.412

2.  Genomic and clinical characteristics of six patients with partially overlapping interstitial deletions at 10p12p11.

Authors:  Christian Wentzel; Evica Rajcan-Separovic; Claudia A L Ruivenkamp; Sandra Chantot-Bastaraud; Corinne Metay; Joris Andrieux; Göran Annerén; Antoinet C J Gijsbers; Luc Druart; Capucine Hyon; Marie-France Portnoi; Eva-Lena Stattin; Catherine Vincent-Delorme; Sarina G Kant; Michelle Steinraths; Sandrine Marlin; Irina Giurgea; Ann-Charlotte Thuresson
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

3.  Do different neurons age differently? Direct genome-wide analysis of aging in single identified cholinergic neurons.

Authors:  Leonid L Moroz; Andrea B Kohn
Journal:  Front Aging Neurosci       Date:  2010-05-19       Impact factor: 5.750

Review 4.  The role of microRNAs in the biology of rare diseases.

Authors:  Marco Salvatore; Armando Magrelli; Domenica Taruscio
Journal:  Int J Mol Sci       Date:  2011-10-11       Impact factor: 5.923

5.  Integrative analyses of genes and microRNA expressions in human trisomy 21 placentas.

Authors:  Ji Hyae Lim; You Jung Han; Hyun Jin Kim; Moon Young Kim; So Yeon Park; Youl-Hee Cho; Hyun Mee Ryu
Journal:  BMC Med Genomics       Date:  2018-05-09       Impact factor: 3.063

6.  miRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability.

Authors:  Ying Qiao; Chansonette Badduke; Eloi Mercier; Suzanne M E Lewis; Paul Pavlidis; Evica Rajcan-Separovic
Journal:  BMC Genomics       Date:  2013-08-10       Impact factor: 3.969

7.  Decreased miRNA expression in Klinefelter syndrome.

Authors:  Laura Cimino; Michele Salemi; Rossella Cannarella; Rosita A Condorelli; Giorgio Giurato; Giovanna Marchese; Sandro La Vignera; Aldo E Calogero
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

8.  MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome.

Authors:  Emin Karaca; Ayça Aykut; Biray Ertürk; Burak Durmaz; Ahmet Güler; Barış Büke; Ahmet Özgür Yeniel; Ahmet Mete Ergenoğlu; Ferda Özkınay; Mehmet Özeren; Mert Kazandı; Fuat Akercan; Sermet Sağol; Cumhur Gündüz; Özgür Çoğulu
Journal:  Balkan Med J       Date:  2017-12-08       Impact factor: 2.021

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.